ASTROGLIAL AND MICROGLIAL ACTIVATION IN THE WISTAR RAT VENTRAL TEGMENTAL AREA AFTER A SINGLE STRIATAL INJECTION OF 6-HYDROXYDOPAMINE

REFERENCES

• Akiyama, H., & McGeer, P. L. (1989). Microglial response to 6-hydroxydopamine-induced substantia nigra lesions. Brain Research, 489, 247–253.
   PubMed Web of Science ®Google Scholar
• Barnéoud, P., Descombris, E., Aubin, N., & Abrous, D. N. (2000). Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system. European Journal of Neuroscience, 12, 322–336.
   PubMed Web of Science ®Google Scholar
• Batchelor, P. E., Liberatore, G. T., Wong, J. Y., Porritt, M. J., Frerichs, F., Donnan, G. A., & Howells, D. W. (1999). Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. Journal of Neuroscience, 19, 1708–1716.
   PubMed Web of Science ®Google Scholar
• Baumann, N., Baron-Van Evercooren, A., Jacque, C., & Zalc, B. (1993). Glial biology and disorders. Current Opinion in Neurology and Neurosurgery, 6, 27–33.
   PubMedGoogle Scholar
• Berger, K., Przedborski, S., & Cadet, J. L. (1991). Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats. Brain Research Bulletins, 26, 301–307.
   PubMed Web of Science ®Google Scholar
• Bignami, A., & Dahl, D. (1976). The astroglial response to stabbing. Immunofluorescence studies with antibodies to astrocyte-specific protein (GFA) in mammalian and submammalian vertebrates. Neuropathology Applied Neurobiology, 2, 99–111.
   Google Scholar
• Björklund, A., & Lindvall, O. (1986). Catecholaminergic brain stem regulatory systems. Intrinsic regulatory systems in the brain. In F. E. Bloom, Handbook of physiology: The nervous system (Vol 4). Bethesda: American Physiological Society.
   Google Scholar
• Björklund, A., Rosenblad, C., Winkler, C., & Kirik, D. (1997). Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson’s disease. Neurobiology Disease, 4, 186–200.
   PubMed Web of Science ®Google Scholar
• Cadet, J. L., Last, R., Kostic, V., Przedborski, S., & Jackson-Lewis, V. (1991). Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate- putamen. Brain Research Bulletins, 26, 707–713.
   PubMed Web of Science ®Google Scholar
• Cadet, J. L., & Zhu, S. M. (1992). The intrastriatal 6-hydroxydopamine model of hemiparkin- sonism: Quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic, as well as postsynaptic nigrostriatal markers in the rat. Brain Research, 595, 316–326.
   PubMed Web of Science ®Google Scholar
• Cerutti, S. M., & Chadi, G. (2000). S100 immunoreactivity is increased in reactive astro- cytes of the visual pathways following a mechanical lesion of the rat occipital cortex. Cell Biology International, 24, 35–49.
   PubMed Web of Science ®Google Scholar
• Chadi, G., Andrade, M. S., Leme, R. J., & Gomide, V. C. (2001). Experimental models of partial lesion of rat spinal cord to investigate neurodegeneration, glial activation, and behavior impairments. International Journal of Neuroscience, 111, 137–165.
   PubMed Web of Science ®Google Scholar
• Chadi, G., Cao, Y., Pettersson, R. F., & Fuxe, K. (1994). Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degene- ration of the nigrostriatal dopamine neurons. Neuroscience, 61, 891–910.
   PubMed Web of Science ®Google Scholar
• Chadi, G., Möller, A., Rosén, L., Janson, A. M., Agnati, L. A., Goldstein, M., Ögren, S. O., Pettersson, R. F., & Fuxe, K. (1993b). Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Experimental Brain Research, 97, 145–158.
   PubMed Web of Science ®Google Scholar
• Chadi, G., Rosén, L., Cintra, A., Tinner, B., Zoli, M., Pettersson, R. F., & Fuxe, K. (1993a). Corticosterone increases FGF-2 (bFGF) immunoreactivity in the substantia nigra of the rat. Neuroreport, 4, 783–786.
   PubMed Web of Science ®Google Scholar
• Chang, J. W., Wachtel, S. R., Young, D., & Kang, U. J. (1999). Biochemical and anatomi- cal characterization of forepaw adjusting steps in rat models of Parkinson’s disease: Studies on medial forebrain bundle and striatal lesions. Neuroscience, 88, 617–628.
   PubMed Web of Science ®Google Scholar
• Fallon, J. H., & Moore, R. Y. (1978). Catecholamine innervation of the basal forebrain, IV. Topography of the dopamine projection to the basal forebrain and neostriatum. Journal of Comparative Neurology, 180, 545–580.
   PubMed Web of Science ®Google Scholar
• Fawcett, J. (1994). Astrocytes and axon regeneration in the central nervous system. Jour- nal of Neurology, 242, S25–S28.
   Google Scholar
• Frautschy, S. A., Walicke, P. A., & Baird, A. (1991). Localization of basic fibroblast growth factor and its mRNA after CNS injury. Brain Research, 553, 291–299.
   PubMed Web of Science ®Google Scholar
• Giulian, D. (1987). Ameboid microglia as effectors of inflammation in the central nervous system. Journal of Neuroscience Research, 18, 155-171, 132–123.
   Google Scholar
• Giulian, D., Li, J., Leara, B., & Keenen, C. (1994). Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neuro- chemistry International, 25, 227–233.
   PubMed Web of Science ®Google Scholar
• Giulian, D., Vaca, K., & Corpuz, M. (1993). Brain glia release factors with opposing ac- tions upon neuronal survival. Journal of Neuroscience, 13, 29–37.
   PubMed Web of Science ®Google Scholar
• Gomide, V. C., & Chadi, G. (1999). The trophic factors S-100beta and basic fibroblast growth factor are increased in the forebrain reactive astrocytes of adult callosotomized rat. Brain Research, 835, 162–174.
   PubMed Web of Science ®Google Scholar
• Goss, J. R., & Morgan, D. G. (1995). Enhanced glial fibrillary acidic protein RNA re- sponse to fornix transection in aged mice. Journal of Neurochemistry, 64, 1351–1360.
   PubMed Web of Science ®Google Scholar
• Hetier, E., Ayala, J., Denefle, P., Bousseau, A., Rouget, P., Mallat, M., & Prochiantz, A. (1988). Brain macrophages synthesize interleukin-1 and interleukin-l mRNAs in vitro. Journal of Neuroscience Research, 21, 391–397.
   PubMed Web of Science ®Google Scholar
• Hollander, M., & Wolfe, D. A. (1973). Non-parametric statistical methods. New York: Wiley.
   Google Scholar
• Hsu, S. M., Raine, L., & Fanger, H. (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry and Cytochemistry, 29, 577–580.
   PubMed Web of Science ®Google Scholar
• Ichitani, Y., Okamura, H., Nakahara, D., Nagatsu, I., & Ibata, Y. (1994). Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: Evidence for cell death in the substantia nigra. Experimental Neurology, 130, 269–278.
   PubMedGoogle Scholar
• Janson, A. M., & Möller, A. (1993). Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: An analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuro- science, 57, 931–941.
   Google Scholar
• Jones, S., & Kauer, J. A. (1999). Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area. Journal of Neuroscience, 19, 9780- 9787.
   Google Scholar
• Kalivas, P. W., Jennes, L., & Miller, J. S. (1985). A catecholaminergic projection from the ventral tegmental area to the diagonal band of Broca: Modulation by neurotensin. Brain Research, 326, 229–238.
   PubMedGoogle Scholar
• Kirik, D., Rosenblad, C., & Björklund, A. (1998). Characterization of behavioral and neuro- degenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydoparnine in the rat. Experimental Neurology, 152, 259–277.
   PubMed Web of Science ®Google Scholar
• Lee, C. S., Sauer, H., & Bjorklund, A. (1996). Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience, 72, 641–653.
   PubMed Web of Science ®Google Scholar
• Matsuura, K., Makino, H., & Ogawa, N. (1997). Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Ex- perimental Neurology, 146, 526–535.
   PubMed Web of Science ®Google Scholar
• Niquet, J., Ben-An, Y., & Represa, A. (1994). Glial reaction after seizure induced hippoc- ampal lesion: Immunohistochemical characterization of proliferating glial cells. Jour- nal of Neurocytology, 23, 641–656.
   PubMedGoogle Scholar
• Ogawa, M., Araki, M., Nagatsu, I., & Yoshida, M. (1989). Astroglial cell alteration caused by neurotoxins: Immunohistochemical observations with antibodies to glial fibrillary acidic protein, laminin, and tyrosine hydroxylase. Experimental Neurology, 106, 187–196.
   PubMed Web of Science ®Google Scholar
• Paxinos, G., & Watson, C. (1986). The rat brain: In stereotaxic coordinates. San Diego: Harcourt Brace Janovich.
   Google Scholar
• Phillipson, O. T. (1979). Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: A horseradish peroxidase study in the rat. Journal of Com- parative Neurology, 187, 117–143.
   PubMedGoogle Scholar
• Przedborski, S., Levivier, M., Jiang, H., Ferreira, M., Jackson-Lewis, V., Donaldson, D., & Togasaki, D. M. (1995). Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience, 67, 631–647.
   PubMed Web of Science ®Google Scholar
• Rodrigues, R. W., Gomide, V. C., & Chadi, G. (2001). Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. International Journal of Neuroscience, 109, 91–126.
   PubMed Web of Science ®Google Scholar
• Rosenblad, C., Kirik, D., & Björklund, A. (2000). Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Experimental Neurology, 161, 503–516.
   PubMed Web of Science ®Google Scholar
• Sauer, H., & Oertel, W. H. (1994). Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience, 59, 401–415.
   PubMed Web of Science ®Google Scholar
• Shao, Y., & McCarthy, K. D. (1994). Plasticity of astrocytes. Glia, 11, 147–155.
   PubMed Web of Science ®Google Scholar
• Sheng, J. G., Shirabe, S., Nishiyama, N., & Schwartz, J. P. (1993). Alterations in striatal glial fibrillary acidic protein expression in response to 6-hydroxydopamine-induced denerv- ation. Experimental Brain Research, 95, 450–456.
   PubMed Web of Science ®Google Scholar
• Streit, W. J., Graeber, M. B., & Kreutzberg, G. W. (1988). Functional plasticity of micro- glia: A review. Glia, 1, 301–307.
   PubMed Web of Science ®Google Scholar
• Strömberg, I., Björklund, H., Dahl, D., Jonsson, G., Sundström, E., & Ölson, L. (1986). Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl- 4-phenyl-l‚2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein im- munohistochemistry. Brain Research Bulletins, 17, 225–236.
   PubMed Web of Science ®Google Scholar
• Takada, M., & Hattori, T. (1987). Organization of ventral tegmental area cells projecting to the occipital cortex and forebrain in the rat. Brain Research, 418, 27–33.
   PubMedGoogle Scholar
• Ungerstedt, U. (1971). Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degene- ration of the nigro-striatal dopamine system. Acta Physiologica Scandinavica Supple- ment, 367, 69–93.
   PubMedGoogle Scholar
• Ungerstedt, U., & Arbuthnott, O. W. (1970). Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Research, 24, 485–493.
   PubMedGoogle Scholar
• van Domburg, P. H., & ten Donkelaar, H. J. (1991). The human substantia nigra and ven- tral tegmental area. A neuroanatomical study with notes on aging and aging diseases. Advances in Anatomy, Embryology and Cell Biology, 121, 1–132.
   PubMedGoogle Scholar